StockTipsArenaBeta

BUY Dr. Reddy's Laboratories Limited — Sumeet Bagadia, Choice Broking

BUYDr. Reddy's Laboratories Limited
Dr. Reddy's Laboratories share price target & all analyst calls

bySumeet Bagadia, Choice BrokingHorizon: NA (inferred Intraday)22 Sept 2026, 10:29 am ISTvia Zee Business (Live)

Entry₹1,215.7Inferred
Target₹1,245
Total upside +2.41% (call closed)
Stop loss₹1,190-2.11% risk
At expiry₹1,209.522 Sept 2026, 3:05 pm
Expired-0.51%
Follow Sumeet Bagadia for new calls(14% target hit, 83 closed calls)Get alertsWatch DRREDDY for new buy/sell callsGet alertsSee 1 active Intraday pick this session

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Nov, 5:28 pm IST
2 supporting0 opposing
Supports the BUY call (2)

Dr. Reddy's Laboratories has entered into an exclusive distribution and marketing agreement with Takeda Biopharmaceuticals India for Qdenga®, a dengue vaccine, in the private market in India. The agre

BSE · Company Update·18 Sept · 4d ago

(opens in new tab)

JM Financial sees up to 28% upside in Dr Reddy’s and Aurobindo Pharma. Should you buy?

NewsEt-Markets·16 Sept · 6d ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Dr. Reddy's Laboratories

All analyst calls on Dr. Reddy's Laboratories

More from Sumeet Bagadia, Choice Broking

Every call and its outcome